학술논문
Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
Document Type
Article
Author
Mammen, A.L.; Pinal-Fernandez, I.; Amato, A.A.; Dimachkie, M.M.; Chinoy, H.; Lilleker, J.B.; Hussain, Y.; Allenbach, Y.; Benveniste, O.; Boroojerdi, B.; Vanderkelen, M.; Delicha, E.M.; Koendgen, H.; Farzaneh-Far, R.; Duda, P.W.; Sayegh, C.; Amato, A.A.; Biliciler, S.; Dimachkie, M.M.; Edmundson, C.; Freimer, M.; Geraci, A.; Machado, P.; Mammen, A.L.; Mozaffar, T.; Soltanzadeh, P.; Suresh, N.; van der Kooi, A.; Appleby, M.; Barohn, R.J.; Champtiaux, N.; Doughty, C.; Farias, J.; Farmakidis, C.; Habib, A.A.; Karam, C.; Lorusso, S.; Pasnoor, M.; Querin, G.; Raaphorst, J.; Ransley, G.; Saba, S.; Sheikh, K.; Snedden, A.; Statland, J.; Vu, T.
Source
In: The Lancet Rheumatology . (The Lancet Rheumatology, 01 February 2023, 5(2):e67-e76)
Subject
Language
English
ISSN
26659913